T. Rowe Price Associates’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35B | Buy |
|
|||||
|
2025
Q1 | $1.64B | Sell |
|
|||||
|
2024
Q4 | $1.56B | Buy |
|
|||||
|
2024
Q3 | $1.57B | Buy |
|
|||||
|
2024
Q2 | $1.36B | Buy |
|
|||||
|
2024
Q1 | $1.4B | Buy |
|
|||||
|
2023
Q4 | $1.15B | Buy |
|
|||||
|
2023
Q3 | $894M | Sell |
|
|||||
|
2023
Q2 | $1.34B | Sell |
|
|||||
|
2023
Q1 | $1.35B | Sell |
|
|||||
|
2022
Q4 | $1.43B | Buy |
|
|||||
|
2022
Q3 | $1.1B | Buy |
|
|||||
|
2022
Q2 | $938M | Buy |
|
|||||
|
2022
Q1 | $1.01B | Sell |
|
|||||
|
2021
Q4 | $1.04B | Buy |
|
|||||
|
2021
Q3 | $1.14B | Buy |
|
|||||
|
2021
Q2 | $974M | Buy |
|
|||||
|
2021
Q1 | $821M | Sell |
|
|||||
|
2020
Q4 | $891M | Sell |
|
|||||
|
2020
Q3 | $888M | Buy |
|
|||||
|
2020
Q2 | $745M | Sell |
|
|||||
|
2020
Q1 | $660M | Buy |
|
|||||
|
2019
Q4 | $920M | Sell |
|
|||||
|
2019
Q3 | $858M | Buy |
|
|||||
|
2019
Q2 | $713M | Buy |
|
|||||
|
2019
Q1 | $751M | Buy |
|
|||||
|
2018
Q4 | $545M | Buy |
|
|||||
|
2018
Q3 | $380M | Buy |
|
|||||
|
2018
Q2 | $265M | Buy |
|
|||||
|
2018
Q1 | $193M | Buy |
|
|||||
|
2017
Q4 | $200M | Buy |
|
|||||
|
2017
Q3 | $190M | Buy |
|
|||||
|
2017
Q2 | $184M | Sell |
|
|||||
|
2017
Q1 | $176M | Buy |
|
|||||
|
2016
Q4 | $140M | Buy |
|
|||||
|
2016
Q3 | $56.8M | Buy |
|
|||||
|
2016
Q2 | $42.8M | Buy |
|
|||||
|
2016
Q1 | $35M | Buy |
|
|||||
|
2015
Q4 | $31.4M | Sell |
|
|||||
|
2015
Q3 | $30.7M | Sell |
|
|||||
|
2015
Q2 | $36M | Buy |
|
|||||
|
2015
Q1 | $36.9M | Buy |
|
|||||
|
2014
Q4 | $33.4M | Buy |
|
|||||
|
2014
Q3 | $28.6M | Buy |
|
|||||
|
2014
Q2 | $29.4M | Buy |
|
|||||
|
2014
Q1 | $25.4M | Sell |
|
|||||
|
2013
Q4 | $42.7M | Sell |
|
|||||
|
2013
Q3 | $58.9M | Sell |
|
|||||
|
2013
Q2 | $58.4M | Buy |
|